e-Therapeutics (LSE:ETX) Total Liabilities : £1.28 Mil (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Total Liabilities?

e-Therapeutics's Total Liabilities for the quarter that ended in Jul. 2023 was £1.28 Mil.

e-Therapeutics's quarterly Total Liabilities increased from Jul. 2022 (£1.18 Mil) to Jan. 2023 (£1.60 Mil) but then declined from Jan. 2023 (£1.60 Mil) to Jul. 2023 (£1.28 Mil).

e-Therapeutics's annual Total Liabilities increased from Jan. 2021 (£0.43 Mil) to Jan. 2022 (£1.79 Mil) but then declined from Jan. 2022 (£1.79 Mil) to Jan. 2023 (£1.60 Mil).

e-Therapeutics Total Liabilities Historical Data

The historical data trend for e-Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Total Liabilities Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Total Liabilities

Get a 7-Day Free Trial

0.71

0.28

0.43

1.79

1.60

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Total Liabilities	Get a 7-Day Free Trial															0.85	1.79	1.18	1.60	1.28

e-Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

e-Therapeutics's Total Liabilities for the fiscal year that ended in Jan. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.596	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.60

Total Liabilities	=	Total Assets (A: Jan. 2023 )	-	Total Equity (A: Jan. 2023 )
	=	34.64	-	33.044
	=	1.60

e-Therapeutics's Total Liabilities for the quarter that ended in Jul. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.276	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.28

Total Liabilities	=	Total Assets (Q: Jul. 2023 )	-	Total Equity (Q: Jul. 2023 )
	=	28.807	-	27.531
	=	1.28

e-Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021